相似文献
1
Current Challenges and Achievements in Maternal Immunization Research.
Front Immunol. 2018 Mar 6;9:436. doi: 10.3389/fimmu.2018.00436. eCollection 2018.
2
Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015.
Vaccine. 2015 Nov 25;33(47):6388-95. doi: 10.1016/j.vaccine.2015.08.047. Epub 2015 Aug 24.
3
Maternal immunization: Optimizing protection for the mother and infant.
J Infect. 2016 Jul 5;72 Suppl:S83-90. doi: 10.1016/j.jinf.2016.04.027. Epub 2016 May 24.
4
Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement.
Front Immunol. 2020 Jun 24;11:1282. doi: 10.3389/fimmu.2020.01282. eCollection 2020.
5
Prospects for prevention of childhood infections by maternal immunization.
Curr Opin Infect Dis. 2006 Jun;19(3):271-6. doi: 10.1097/01.qco.0000224822.65599.5b.
6
Who's the Target: Mother or Baby?
Viral Immunol. 2018 Mar;31(2):184-194. doi: 10.1089/vim.2017.0135. Epub 2018 Feb 23.
7
Regulatory considerations for study of infant protection through maternal immunization.
Vaccine. 2022 Jun 9;40(26):3556-3565. doi: 10.1016/j.vaccine.2022.04.087. Epub 2022 May 12.
8
Immunization of pregnant women: Future of early infant protection.
Hum Vaccin Immunother. 2015;11(11):2549-55. doi: 10.1080/21645515.2015.1070984. Epub 2015 Sep 14.
9
Prospects for vaccines during pregnancy and in the newborn period.
Clin Perinatol. 1997 Mar;24(1):231-49.
10
The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next Generation.
mSphere. 2021 Jan 27;6(1):e00862-20. doi: 10.1128/mSphere.00862-20.
引用本文的文献
1
Prevalence and Predictors of Adverse Birth Outcomes and Their Implications in Assessing the Safety of New Maternal Vaccines in Kenya.
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S114-S118. doi: 10.1097/INF.0000000000004660. Epub 2025 Feb 14.
2
Vitamin D Metabolites in Mother-Infant Dyads and Associated Clinical Outcomes in a Population of Nigerian Women.
Nutrients. 2024 Jun 13;16(12):1857. doi: 10.3390/nu16121857.
3
The Impact of Sociodemographic, Macroeconomic, and Health Status and Resources on Infant Mortality Rates in Oman: Evidence from 1980 to 2022.
Eur J Investig Health Psychol Educ. 2023 Jun 7;13(6):986-999. doi: 10.3390/ejihpe13060075.
4
Adverse infant outcomes following low-risk pregnancies in England: a retrospective cohort study.
BMC Pregnancy Childbirth. 2023 May 9;23(1):330. doi: 10.1186/s12884-023-05598-2.
5
Safety and Immunogenicity of Pertussis Vaccine Immunization during Pregnancy: A Meta-Analysis of Randomized Clinical Trials.
J Trop Med. 2022 Dec 21;2022:4857872. doi: 10.1155/2022/4857872. eCollection 2022.
6
Antibodies against SARS-CoV-2 Alpha, Beta, and Gamma Variants in Pregnant Women and Their Neonates under Antenatal Vaccination with Moderna (mRNA-1273) Vaccine.
Vaccines (Basel). 2022 Aug 28;10(9):1415. doi: 10.3390/vaccines10091415.
7
Facilitating safety evaluation in maternal immunization trials: a retrospective cohort study to assess pregnancy outcomes and events of interest in low-risk pregnancies in England.
BMC Pregnancy Childbirth. 2022 Jun 1;22(1):461. doi: 10.1186/s12884-022-04769-x.
8
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Front Immunol. 2022 Apr 28;13:880368. doi: 10.3389/fimmu.2022.880368. eCollection 2022.
9
The Protective Role of Maternal Immunization in Early Life.
Front Pediatr. 2021 Apr 28;9:638871. doi: 10.3389/fped.2021.638871. eCollection 2021.
10
Vaccinating for Whom? Distinguishing between Self-Protective, Paternalistic, Altruistic and Indirect Vaccination.
Public Health Ethics. 2020 Mar 11;13(2):190-200. doi: 10.1093/phe/phaa005. eCollection 2020 Jul.
本文引用的文献
1
The thalidomide tragedy: the struggle for victims' rights and improved pharmaceutical regulation.
Hist Cienc Saude Manguinhos. 2017 Jul-Sep;24(3):603-622. doi: 10.1590/S0104-59702017000300004.
2
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
Vaccine. 2017 Jun 27;35(30):3749-3759. doi: 10.1016/j.vaccine.2017.05.045. Epub 2017 Jun 1.
3
Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.
Lancet Infect Dis. 2017 Sep;17(9):981-989. doi: 10.1016/S1473-3099(17)30252-9. Epub 2017 May 15.
4
Maternal immunisation: collaborating with mother nature.
Lancet Infect Dis. 2017 Jul;17(7):e197-e208. doi: 10.1016/S1473-3099(17)30229-3. Epub 2017 Apr 19.
5
Pertussis and influenza immunisation during pregnancy: a landscape review.
Lancet Infect Dis. 2017 Jul;17(7):e209-e222. doi: 10.1016/S1473-3099(17)30190-1. Epub 2017 Apr 19.
6
Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.
Lancet Infect Dis. 2017 Jul;17(7):e223-e234. doi: 10.1016/S1473-3099(17)30232-3. Epub 2017 Apr 19.
7
Maternal immunization.
Birth Defects Res. 2017 Mar 15;109(5):379-386. doi: 10.1002/bdra.23547.
8
Overcoming Barriers and Identifying Opportunities for Developing Maternal Immunizations: Recommendations From the National Vaccine Advisory Committee.
Public Health Rep. 2017 May/Jun;132(3):271-284. doi: 10.1177/0033354917698118. Epub 2017 Apr 5.
9
The Common Rule, Updated.
N Engl J Med. 2017 Feb 16;376(7):613-615. doi: 10.1056/NEJMp1700736. Epub 2017 Jan 19.
10
Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction.
Clin Infect Dis. 2016 Dec 1;63(suppl 4):S236-S243. doi: 10.1093/cid/ciw559.
Zotero 插件